Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
99.3 EUR | +0.05% | +0.61% | -1.29% |
May. 10 | BioMérieux: the rebound gains momentum, an analyst reinforces its case | CF |
Apr. 26 | BioMérieux: share price rises, analyst remains Buy | CF |
Sales 2024 * | 3.9B 4.2B | Sales 2025 * | 4.19B 4.51B | Capitalization | 11.73B 12.64B |
---|---|---|---|---|---|
Net income 2024 * | 467M 503M | Net income 2025 * | 527M 568M | EV / Sales 2024 * | 2.94 x |
Net cash position 2024 * | 263M 284M | Net cash position 2025 * | 444M 478M | EV / Sales 2025 * | 2.69 x |
P/E ratio 2024 * |
25.7
x | P/E ratio 2025 * |
22.8
x | Employees | 13,696 |
Yield 2024 * |
0.87% | Yield 2025 * |
1.01% | Free-Float | 36.21% |
Latest transcript on bioMérieux
1 day | +0.05% | ||
1 week | +0.61% | ||
Current month | -0.70% | ||
1 month | -4.70% | ||
3 months | -3.22% | ||
6 months | +7.03% | ||
Current year | -1.29% |
Managers | Title | Age | Since |
---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 16-10-31 |
Chairman | 50 | 04-04-15 | |
Director of Finance/CFO | 47 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 06-09-14 | |
Director/Board Member | 63 | 04-12-31 | |
Chairman | 50 | 04-04-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.97% | 0 M€ | -4.02% | ||
0.26% | 0 M€ | +3.57% | ||
0.24% | 5 M€ | +4.56% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 99.3 | +0.05% | 126,188 |
24-05-09 | 99.25 | +0.15% | 45,551 |
24-05-08 | 99.1 | -0.70% | 70,365 |
24-05-07 | 99.8 | +0.40% | 73,190 |
24-05-06 | 99.4 | +0.71% | 54,656 |
Real-time Euronext Paris, May 10, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.29% | 12.64B | |
-0.47% | 8.46B | |
+5.68% | 5.66B | |
+22.61% | 5.27B | |
-2.03% | 4.49B | |
-53.56% | 3.11B | |
+19.30% | 2.87B | |
-8.42% | 2.23B | |
-3.55% | 1.89B | |
+5.37% | 1.64B |
- Stock Market
- Equities
- BIM Stock